HOOLEY JOSEPH L 4
4 · IDEXX LABORATORIES INC /DE · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
IDEXX (IDXX) Director Joseph Hooley Receives 36 Deferred Shares
What Happened
Joseph L. Hooley, a director of IDEXX Laboratories (IDXX), was granted 36 deferred stock units on 2026-01-30 at an imputed price of $670.46 per unit, a total value of approximately $24,137. The Form 4 reports this as an award/acquisition (code A) under the IDEXX Director Deferred Compensation Plan.
Key Details
- Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (appears timely under the two-business-day rule).
- Grant: 36 deferred stock units at $670.46 per unit; aggregate reported value $24,137.
- Footnote: Units were issued pursuant to the IDEXX Director Deferred Compensation Plan. The number of units was determined by dividing $24,375.00 of deferred cash compensation by the closing stock price and rounding to a whole unit (hence 36 units).
- Vesting and payment: Units vest immediately but are payable only as common stock upon the director’s resignation from the board or on other nondiscretionary, objectively determinable dates per the Plan. Each unit represents a contingent right to one share.
- Shares owned after the transaction: not specified in the filing.
Context
This was an award of deferred stock units (not an open-market purchase or sale). Such grants are routine compensation for directors and do not by themselves indicate a change in insider sentiment. The units convert to shares only under the Plan’s payout conditions and are intended as deferred compensation.
Insider Transaction Report
Form 4
HOOLEY JOSEPH L
Director
Transactions
- Award
Common Stock
[F1]2026-01-30$670.46/sh+36$24,137→ 75 total
Footnotes (1)
- [F1]Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($24,375.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Joseph L. Hooley|2026-02-03